Exosomal TRIM3 is a novel marker and therapy target for gastric cancer

[1]  Bing Zhou,et al.  Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development , 2016, Scandinavian journal of gastroenterology.

[2]  Christian Pilarsky,et al.  Glypican-1 identifies cancer exosomes and detects early pancreatic cancer , 2015, Nature.

[3]  Michael A. Hollingsworth,et al.  Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver , 2015, Nature Cell Biology.

[4]  S. Mathivanan,et al.  Exosomes in bodily fluids are a highly stable resource of disease biomarkers , 2015, Proteomics. Clinical applications.

[5]  Erwin G. Van Meir,et al.  Human Brat ortholog TRIM3 is a tumor suppressor that regulates asymmetric cell division in glioblastoma. , 2014, Cancer research.

[6]  Clotilde Théry,et al.  Biogenesis and secretion of exosomes. , 2014, Current opinion in cell biology.

[7]  Jing-jing Zhao,et al.  Decreased expression of TRIM3 is associated with poor prognosis in patients with primary hepatocellular carcinoma , 2014, Medical Oncology.

[8]  S. Kondo,et al.  Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes , 2014, Oncogene.

[9]  A. Koff,et al.  The ability of TRIM3 to induce growth arrest depends on RING-dependent E3 ligase activity. , 2014, The Biochemical journal.

[10]  A. Llorente,et al.  Exosomal miRNAs as Biomarkers for Prostate Cancer , 2013, Front. Genet..

[11]  C. Brennan,et al.  TRIM3, a tumor suppressor linked to regulation of p21Waf1/Cip1 , 2013, Oncogene.

[12]  P. Hainaut,et al.  Tumor-cell-derived microvesicles as carriers of molecular information in cancer , 2013, Current opinion in oncology.

[13]  R. Coffey,et al.  Proteomic Analysis of Exosomes from Mutant KRAS Colon Cancer Cells Identifies Intercellular Transfer of Mutant KRAS* , 2012, Molecular & Cellular Proteomics.

[14]  S. Rai,et al.  Identifying mRNA, MicroRNA and Protein Profiles of Melanoma Exosomes , 2012, PloS one.

[15]  M. Michael,et al.  Hypoxic enhancement of exosome release by breast cancer cells , 2012, BMC Cancer.

[16]  M. Wood,et al.  Exosomes and the emerging field of exosome-based gene therapy. , 2012, Current gene therapy.

[17]  R. Setterquist,et al.  Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. , 2012, Biochimica et biophysica acta.

[18]  Gema Moreno-Bueno,et al.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.

[19]  E. Cisneros,et al.  Analysis of exosome release and its prognostic value in human colorectal cancer , 2012, Genes, chromosomes & cancer.

[20]  D. Webb,et al.  Identification and proteomic profiling of exosomes in human cerebrospinal fluid , 2012, Journal of Translational Medicine.

[21]  S. Hatakeyama,et al.  TRIM proteins and cancer , 2011, Nature Reviews Cancer.

[22]  T. Whiteside,et al.  Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-β1 , 2011, Haematologica.

[23]  S. Wickline,et al.  Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. , 2011, Cancer research.

[24]  Guido Jenster,et al.  Exosomes as biomarker treasure chests for prostate cancer. , 2011, European urology.

[25]  D. Lyden,et al.  The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. , 2011, Seminars in cancer biology.

[26]  H. Katai,et al.  Present and future status of gastric cancer surgery. , 2011, Japanese journal of clinical oncology.

[27]  Aled Clayton,et al.  Cancer exosomes trigger fibroblast to myofibroblast differentiation. , 2010, Cancer research.

[28]  S. Mathivanan,et al.  Exosomes: extracellular organelles important in intercellular communication. , 2010, Journal of proteomics.

[29]  M. Biffoni,et al.  Caveolin‐1 tumor‐promoting role in human melanoma , 2009, International journal of cancer.

[30]  C. Théry,et al.  Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.

[31]  F. Hirth,et al.  Loss of heterozygosity of TRIM3 in malignant gliomas , 2009, BMC Cancer.

[32]  Johan Skog,et al.  Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers , 2008, Nature Cell Biology.

[33]  Douglas D. Taylor,et al.  Exosomal microRNA: a diagnostic marker for lung cancer. , 2008, Clinical lung cancer.

[34]  Cicek Gercel-Taylor,et al.  MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. , 2008, Gynecologic oncology.

[35]  A. Guha,et al.  Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells , 2008, Nature Cell Biology.

[36]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[37]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.

[38]  William E. Grizzle,et al.  Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function1 , 2006, The Journal of Immunology.

[39]  Bart N Lambrecht,et al.  Proteomic analysis of exosomes isolated from human malignant pleural effusions. , 2004, American journal of respiratory cell and molecular biology.

[40]  Tesshi Yamada,et al.  BERP, a Novel Ring Finger Protein, Binds to α-Actinin-4 , 2000 .

[41]  S. Vincent,et al.  Cloning and Characterization of a Novel RING Finger Protein That Interacts with Class V Myosins* , 1999, The Journal of Biological Chemistry.

[42]  P. Pelicci,et al.  TRIM proteins in cancer. , 2012, Advances in experimental medicine and biology.

[43]  S. Hirohashi,et al.  BERP, a novel ring finger protein, binds to alpha-actinin-4. , 2000, Biochemical and biophysical research communications.

[44]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.